291 GENES FOUND

? »

Page of 6 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ABAT4-aminobutyrate aminotransferaseDisease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Predicted intracellular proteins
Tissue enhanced
ABCC1ATP-binding cassette, sub-family C (CFTR/MRP), member 1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
ABCC2ATP-binding cassette, sub-family C (CFTR/MRP), member 2Cancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Group enriched
ABL1ABL proto-oncogene 1, non-receptor tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Expressed in all
ACEAngiotensin I converting enzymeCandidate cardiovascular disease genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Group enriched
ACE2Angiotensin I converting enzyme 2Enzymes
FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
ADAAdenosine deaminaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enriched
ADH1AAlcohol dehydrogenase 1A (class I), alpha polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enriched
ADH1BAlcohol dehydrogenase 1B (class I), beta polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Group enriched
ADH1CAlcohol dehydrogenase 1C (class I), gamma polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Group enriched
ADKAdenosine kinaseDisease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
ADRB1Adrenoceptor beta 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
AGTR1Angiotensin II receptor, type 1Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Group enriched
AKR1C2Aldo-keto reductase family 1, member C2Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
AKR1D1Aldo-keto reductase family 1, member D1Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Tissue enriched
ALADAminolevulinate dehydrataseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
ALPPL2Alkaline phosphatase, placental-like 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
AMY2AAmylase, alpha 2A (pancreatic)Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
ANXA1Annexin A1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
Expressed in all
AOC3Amine oxidase, copper containing 3Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
APEX1APEX nuclease (multifunctional DNA repair enzyme) 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
ARAndrogen receptorCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
Tissue enhanced
ATIC5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
ATP2C1ATPase, Ca++ transporting, type 2C, member 1Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Transporters
Expressed in all
ATP4AATPase, H+/K+ exchanging, alpha polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enriched
ATP6V1B2ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2FDA approved drug targets
Predicted intracellular proteins
Transporters
Expressed in all
BCL2B-cell CLL/lymphoma 2Cancer-related genes
Disease related genes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
BCRBreakpoint cluster regionCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
BLVRBBiliverdin reductase B (flavin reductase (NADPH))Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
BRAFB-Raf proto-oncogene, serine/threonine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
C3Complement component 3Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
CA1Carbonic anhydrase IEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Group enriched
CA14Carbonic anhydrase XIVEnzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
CA2Carbonic anhydrase IIDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enhanced
CA3Carbonic anhydrase III, muscle specificEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enriched
CA4Carbonic anhydrase IVDisease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
CACNA1ACalcium channel, voltage-dependent, P/Q type, alpha 1A subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1CCalcium channel, voltage-dependent, L type, alpha 1C subunitDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1SCalcium channel, voltage-dependent, L type, alpha 1S subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
CACNA2D1Calcium channel, voltage-dependent, alpha 2/delta subunit 1FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Mixed
CASRCalcium-sensing receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enhanced
CATCatalaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
CCND1Cyclin D1Cancer-related genes
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
CD2CD2 moleculeCD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD247CD247 moleculeCD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
CD33CD33 moleculeCD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Mixed
CD3DCD3d molecule, delta (CD3-TCR complex)CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD3ECD3e molecule, epsilon (CD3-TCR complex)CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
CD3GCD3g molecule, gamma (CD3-TCR complex)CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
CD4CD4 moleculeCD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all

Page of 6 | next »